Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
Washingtoner/10311708

SAN DIEGO - Washingtoner -- Melospeech Inc., a leading innovator in early-intervention and pediatric speech therapy technology, announced today that it has officially accepted its nomination for HealthTech Startup of the Year in the United States for the Northern American Startup Awards, Edition 11.

This nomination recognizes Melospeech Inc.'s impact in advancing technology-enabled speech therapy, expanding access for underserved families, and building scalable tools that help practices operate with greater efficiency. Finalists across the Global Startup Awards network represent the top emerging companies, with 16 past finalists reportedly achieving unicorn status.

"We're excited to stand alongside so many other health tech start-ups in officially accepting this nomination," said Dr. Givona Sandiford, founder and CEO of Melospeech Inc. "Our team was genuinely surprised by the recognition. We're just a small group of therapists, developers, and educators working to reach as many underserved children as we can — and technology is what makes that possible."

More on Washingtoner

• Rande Vick Introduces Radical Value, Challenging How Brands Measure Long-Term Value
• Lisa Mauretti Launches Peace of Mind Travel Coaching to Guide Fearful Travelers to Discover the World with Confidence
• New Year, New Home: Begin 2026 at Heritage at South Brunswick
• Food Journal Magazine Releases Its 'Best Food In Los Angeles Dining' Editorial Section
• Enders Capital: 25% Gains with Just -0.80% Maximum Monthly Drawdown in Volatile Debut Year 2025

Kelli Bavaro, Deputy CEO of Melospeech Inc., also shared her perspective on the company's nomination and use of proprietary technology.

"As a speech-language pathologist, I've seen firsthand how powerful it is when we meet families where they are—both physically and culturally," said Bavaro. "What makes Melospeech so unique is our commitment to using technology and innovation that's truly built for our field, allowing us to better and more quickly serve communities in need."

The nomination also provides opportunities for Melospeech Inc. to gain additional visibility within the global innovation ecosystem, connect with influential industry leaders, and access potential investment opportunities through GSA Ventures.

Melospeech Inc. will complete the next phase of the awards process and looks forward to the opportunity to represent the healthtech community on both national and international stages.

More on Washingtoner

• Beat the Winter Blues: Paws, Play & Positivity Pop-Up Class Supports Pets and Their People This January
• CES Spotlight Highlights Need for Strategic Review as Throughput Demands Evolve
• ASR Media, Social T Marketing & PR Announce Merger
• $780,000 Project for New Middle East Police Service with Deposit Received and Preliminary Design Work Underway for Lamperd: Stock Symbol: LLLI
• The 3rd Annual Newark Summit for Real Estate, Economic Development & Placemaking Returns February 9th

About Melospeech Inc.
Melospeech Inc. is a nationally recognized pediatric speech therapy provider specializing in early intervention, parent empowerment, and community-based care. Through innovative technology—including the MeloSuite, the SLPeaceBot™, and other proprietary tools—Melospeech has expanded its reach across underserved regions while streamlining clinical workflows and improving outcomes. Founded by Dr. Givona Sandiford, Melospeech has grown from a solo practice into a multi-state organization providing tens of thousands of sessions each year.